| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |